Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -1431.00x as of the fiscal period ended Tuesday, March 31, 2020.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-1431.00x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 329 covered companies
CURRENT VS SECTOR MEDIAN
-33971.43%
vs the sector median at left
Monte Rosa Therapeutics, Inc.
Market Cap
$867.60M
Interest Coverage Ratio
-1431.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$856.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$850.75M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$903.13M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$819.44M
Interest Coverage Ratio
N/A
TTM Avg
85.72x
3Y Avg
85.72x
5Y Avg
85.72x
Market Cap
$914.60M
Interest Coverage Ratio
2.21x
TTM Avg
2.21x
3Y Avg
2.21x
5Y Avg
5.08x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | $867.60M | -1431.00x | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $873.72M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $856.30M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $850.75M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $850.45M | N/A | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $837.43M | -1.44x | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $819.44M | N/A | 85.72x | 85.72x | 85.72x |
| Bioventus Inc. (BVS)vs › | $914.60M | 2.21x | 2.21x | 2.21x | 5.08x |
| HealthStream, Inc. (HSTM)vs › | $921.45M | N/A | 204.36x | 142.82x | 142.82x |
Interest Coverage
-1431.0x
Debt/Equity
0.08
Current Ratio
9.52
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2020-03-31 | -1431.00x |
